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ABSTRACT
Air pollution poses a significant threat to the environment and human health. Most in vivo health studies conducted regarding air pollutants,
including particulate matter (PM) and gas phase pollutants, have been either through traditional medical intranasal treatment or using a tiny
chamber, which limit animal activities. In this study, we designed and tested a large, whole-body, multiple animal exposure chamber with
uniform dispersion and exposure stability for animal studies. The chamber simultaneously controls particle size distribution and PM mass
concentration. Two different methods were used to generate aerosol suspension through either soluble material (Alternaria extract), liquid
particle suspension (nanosilica solution), or dry powder (silica powder). We demonstrate that the chamber system provides well controlled
and characterized whole animal exposures, where dosage is by inhalation of particulate matter.
Published under license by AIP Publishing. https://doi.org/10.1063/1.5042097
I. INTRODUCTION
Air pollution is the presence in the outdoor atmosphere of one
or more contaminants, which include particulates, gases, vapors,
compounds, or biological materials in quantities, characteristics,
and durations that are either damaging to property or injurious
to human, plant, or animal life. Particulate matter (PM), includ-
ing PM2.5 (particulate matter with aerodynamic diameter less than
2.5 µm) and coarser particles like dust and pollens, is major atmo-
spheric air contaminant that continues to a pose significant threat
to human health.1–3 In recent years, extensive studies have inves-
tigated the resultant health effects of exposure to PM on human
and model organisms. Numerous epidemiological studies have
consistently demonstrated that air pollution is strongly associated
with the morbidity and mortality from multiple cardiopulmonary
and lung diseases; results indicate that PM2.5 has far more impacts
on health than heretofore recognized.4–9 One major factor is the
relatively high deposition fraction of particles smaller than 2.5 µm
in all regions of the lungs. PM2.5 will even reach the alveoli while
inhaled nanoparticles can pass from the lungs into the bloodstream
and extrapulmonary organs. Studies in mice have demonstrated an
accumulation in the blood and liver following pulmonary exposure
to a broader size range of 2–200 nm.10
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FIG. 1. Schematic of the chamber system, including four main components: (1) clean air system, (2) aerosol generation system, (3) chamber system, and (4) sample
monitoring system.
This chamber system allows for a route of exposure that sim-
ulates naturally occurring inhalation, as opposed to the most com-
mon method to study mouse exposures to environmental challenges.
In fact, intranasal delivery may not be representative of common
exposures. During an intranasal treatment, a mouse is held in a
supine position while a micropipette is placed at the external nares
and a concentrated solution is trickled in slowly.11,12 Heightened
concerns regarding the use of intranasal treatment, and its lack of
relevance to common human exposure modes, has motivated our
research aimed at exposing mice via inhalation in this study.
For better understanding the health impacts of air pollution
exposure, we constructed a large-scale chamber for exposure to
multiple pollutants. Featuring on whole-body exposure, this cham-
ber houses up to 18 mice in separate cages for each experiment
(Fig. 1) with its large dimension of 540 l, which is much larger than
other chambers (Table I).13–16 Compared to other chronic expo-
sure chambers featuring nose-only exposures that limit the animal
activities and only allow short term exposure for each test,17–19 our
chamber frees the mice in a natural way of inhalation and delivers
7 consecutive days of exposure until the need of changing beddings
or adding food supplies. Using our chamber system, we are capa-
ble of uniformly dispersing particles with sizes ranging from coarse
mode particles (e.g., dust) to fine particulate matters (nano-sized
particles) at controlled size distributions and concentrations, while
maintaining stability.
TABLE I. Comparison of different existing chamber systems.
Chamber Exposure
Chamber systems type/size (L) duration (Hrs/day)
Ye et al.38 Nose only 1–2
Mainelis et al.19 Nose only 1
Ko et al.13 1 0.2
Kang et al.15 6.3 6
Hougaard et al.16 18 1
Peng et al.35 540 24
II. CHAMBER DESCRIPTION
A. Clean air system
Lab compressed air is passed through a filter system (Speedaire
Compress Air Filter-4ZL51, Grainger, Illinois, USA) prior to enter-
ing an atomizer/particle disperser (Fig. 1). The filter system con-
sists of silica gel (absorbs water moisture), activated carbon (absorbs
organics), Hopcalite (absorbs CO), Purafil (absorbs NOx), and a
high-efficiency particulate air (HEPA) filter (absorbs 99.97% of air-
borne particles). The total flowrate of the nebulizer injection system
is 6 l/min, while the small scale powder disperser (SSPD) injec-
tion system flowrate ranges from 12 to 20 l/min. When flushing
the chamber with clean air before/after each experiment, organics,
CO, and NOx concentration were below the detection limit of the
hydrocarbon/CO/NOx gas analyzer.
B. Aerosol generation system
The aerosol generation system consists of two parts, including
a house-built atomizer for generating aerosol sprays from multiple
liquid solutions and a small scale powder disperser for dispersing
dry powder from the surface of a turntable.
1. Atomizer for nanoparticles
A stainless-steel atomizer generates aerosol from an ultrapure
water solution of target pollutants. Compressed air passes through
an orifice that creates an air jet which breaks up the solution, which
is then sucked up via a reduction in static pressure, generating a con-
tinuous wet aerosol spray from the solution.20 The wet aerosol is
then routed through a heated copper coil at 127 F to transform water
moisture into vapor, which is absorbed when passed through a dif-
fuser dryer filled with indicator silica gel, replaced daily. This is to
provide a pure particle dose in the nano-size range since the nebu-
lizer aerosol spray produces a particle size at the micron level. The
dried aerosols are subsequently injected into the second component,
the mouse chamber. The atomizer design continuously delivers
nano-sized aerosol with consistent size distribution and mass con-
centration throughout the exposure period. The mass concentration
is controlled through the concentration of aqueous solution.
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2. Small scale powder disperser (SSPD)
An SSPD from TSI (Model 3433, TSI, Minnesota, USA) was
used to disperse target pollutants in powder forms, which are insol-
uble in water, as well as micron-sized particles from 0.5 µm to 50 µm
efficiently. Powders were loaded on a turntable that rotates at speeds
ranging from 0.25 to 3.3 rev/h. A stainless-steel capillary positioned
just above the turntable removes powder from the surface of a
turntable; the shear forces created by two flows deagglomerates the
powder, which enters an expansion cone and is exhausted from the
instrument and then enters the chamber. In this design, the SSPD
delivers a continuous powder aerosol dose for 4 h for each loading
of powder on the turntable. Exposure times and mass concentrations
are controlled by changing the rotation speed of the turntable.
C. Chamber system
The mouse chamber is made of 6 clear acrylic sheets with
a thickness of ¼ in. The total chamber volume is approximately
540 l with external dimensions of 101.6 × 81.3 × 63.6 cm3 (length× width × height). Two porous aluminum plates were used to help
deliver uniform dispersion by separating the aerosol inlet (upper
left) and sampling ports (lower right). The large size of the chamber
allows up to six mouse cages (carrying up to three mice each under
normal laboratory conditions) to fit in simultaneously for exposure
tests. A light-emitting diode (LED) warm light string attached to a
timer switch simulates a light cycle for experimental mice daily by
switching on at 7 a.m. and off at 7 p.m.
To avoid light contamination, the whole chamber is covered
with a customized blackout cloth and a small detachable window
allows observance of mice during the exposure tests. A ¼ in. inlet
from the upper left of the chamber was used for injection, while four
½ in. exhaust ports located in the lower right chamber ensured that
the in-chamber pressure would not build up during aerosol injec-
tion. Another ¼ in. outlet located below the exhaust tubes was used
for sampling monitoring. Before and after each test, the chamber was
flushed with particle free air of at least ten chamber volumes to avoid
contamination.
D. Sample monitoring systems
Three instruments were attached to the chamber sample port
to monitor the experiments.
1. Size distribution and concentration measurements
Aerosol size distribution and concentration during the experi-
ments are recorded by using two different instrument systems. The
Scanning Mobility Particle Sizer (SMPS) (Model 3080 Electrostatic
Classifier using Kr85, TSI, Minnesota, USA) and Condensation Par-
ticle Counter (CPC) (Model 3776, TSI, Minnesota, USA) system is
used to measure particles in the range of 2 nm–1000 nm, while the
Laser Aerosol Particle Size Spectrometer (LAP) (TOPAS, Germany)
provides information of particle size ranging from 0.2 µm to 40 µm.
The SMPS-CPC system is widely used as a standard method for char-
acterization of particles smaller than 1 µm in diameter with a high
resolution of up to 167 channels.21,22 The sheath flow rate of SMPS
was set at 3 LPM, while the CPC aerosol flow rate was set at 0.3 LPM
for a 10:1 ratio. The LAP served as a supplemental instrument for
detecting micron sized particles with a high resolution of up to 128
channels.
2. Total PM mass concentration measurements
The DustTrakTM (TSI, Minnesota, USA) aerosol monitor pro-
vides real-time aerosol mass readings using a light-scattering laser
photometer. When equipped with different size impactors, the
DustTrak measures aerosol concentrations corresponding to PM1,
PM2.5, or PM10, ranging from 0.001 to 400 mg/m3.
III. TARGET POLLUTANTS
Multiple target pollutants, either field collected samples
(swine dust/Salton Sea samples) or industrial products (nanosil-
ica/Alternaria/silica powder), were injected into the chamber
through the aerosol generation system. While the dry silica pow-
der with highest density (Fig. 2) was dispersed using the SSPD 3433,
other targets were nebulized from aqueous solutions and their size
distributions can be found in Fig. 6. The purpose of nebulizing
targets that are soluble in water was to consistently produce nano-
sized particles with stable size distribution and mass concentration
regardless of their density, instead of reproducing environmental
particles in their original physical properties. All five particle sus-
pensions in the chamber were of a size distribution to allow deep
penetration into the lungs and even potential penetration into the
bloodstream and extrapulmonary organs.
A. Fungal extract solution
The fungus Alternaria alternata is a common allergen,
widespread in many indoor and outdoor habitats, found to thrive on
various types of vegetation. Contact with this fungus is unavoidable,
given that Alternaria produces thousands of spores per cubic meter
of air.24,25 Alternaria poses a general health threat as one of the most
abundant sources of aeroallergens known to trigger immune sensi-
tization and as a primary risk factor for the development of asthma.
Furthermore, exposure to Alternaria alternata in previously sensi-
tized individuals is correlated with a severe increased risk of morbid-
ity and a higher risk of fatal asthma attacks.24–27 In children raised in
desert environments, natural exposure to Alternaria spores induces
allergic rhinitis symptoms and serves as a major allergen causing
FIG. 2. Densities of five target particle suspension in the environmental cham-
ber. Density data were obtained using an Aerosol Particle Mass Analyzer
(APM)/Scanning Mobility Particle Spectrometer (SMPS) setup, which has been
modified to achieve higher transmission of particles and improved sampling
frequency.23
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juvenile allergic asthma.24–26,28,29 In this study, we nebulized an
Alternaria extract solution and monitored the size distribution of
Alternaria aerosol using the SMPS.
B. Salton Sea dust
Salton Sea-adjacent airborne particles were obtained by using
passive collectors consisting of Teflon-coated round pans (25.4 cm
in diameter) filled with quartz marbles suspended from the pan
bottom with Teflon mesh and capped with two overarching cross-
braces covered in Tanglefoot to discourage roosting by birds.30 All
materials in contact with dust (i.e., pan, marbles, and Teflon mesh)
were pre-washed prior to installation using first bleach, then distilled
2M HCl, and finally distilled 3M HNO3 with rinses of >18.2 MΩ
cm water between each reagent cleaning step. The collectors were
deployed on 2.4 m tall wooden posts in open areas at each on the
field sites to minimize local contributions of material from wind-
suspended soil (i.e., from saltation) and nearby trees. Collectors
were deployed continuously from December 2015 through March
2017 at the Dos Palmas Preserve, at 33○29’22.1”N 115○50’06.3”W.
To recover dust samples from each collector in March 2017, we
rinsed the marbles with >18.2 MΩ cm water into the Teflon-coated
pan, removing the marbles and mesh, then transferring the water
and dust suspension to pre-cleaned 1 l LDPE Nalgene bottles. The
samples were frozen and stored either at −20 or 4 ○C until use.
C. Swine facility dust
Dusts were also collected from swine concentrated animal feed-
ing operations and prepared into a sterile aqueous extract solu-
tion.31 Briefly, settled surface dusts were collected off horizontal
surfaces within swine confinement facilities (500–700 animals per
facility). Collections were obtained from surfaces located approx-
imately three feet above the floor of the facilities. Dusts obtained
in this manner are routinely characterized for major determinants,
including endotoxin and muramic acid concentrations to determine
relative uniformity of samples across collection facilities and sea-
sons. Detailed analyses of these and other determinants have been
previously published.32–34 Following collection, dust samples were
placed in a buffered saline solution at 100 mg/ml concentration.
Following a 1-h incubation, samples were centrifuged to pellet all
course particles and the supernatant fractions were filtered through a
0.22 µm pore filter. Aqueous extracts obtained following filtration
were considered a 100% stock concentration and were frozen at−20 ○C until use.
D. Nanosilica and ground silica powder
The 100 nm non-functionalized NanoXactTM silica (nanoCom-
posix, Inc, California, USA) are produced via the condensation of
silanes from nanoparticles that consists of an amorphous network
of silicon and oxygen, and the particles are monodisperse with nar-
row size distributions. The particles are readily suspended in polar
solvents such as water and ethanol.
The MIN-U-SIL 5 GROUND SILICA powder (Western
Reserve Chemical, Ohio, USA) is a natural, fine ground silica with
high purity. The consistent pH and narrow size distributions allow
very high loading with minimal effect on viscosity and cure rate ver-
sus synthetic silicas. The high quality, inert, white crystalline silica is
FIG. 3. Size distribution comparison of factory provided and lab nebulized nano-
silica size distribution.
available in five size distributions (5, 10, 15, 30, and 40 µm topsize).
The comparison of the factory provided silica particle distribution
and the lab nebulized distribution can be found in Fig. 3.
IV. RESULTS AND DISCUSSIONS
A. Mass concentration across the chamber
Figure 4 shows the PM2.5 concentration of aerosolized ammo-
nium nitrate (NH4NO3) solution in six different locations of the
chamber plate with a standard deviation of 1.97. The DustTrak was
placed inside the chamber at six locations, with the sampling port at
the height of ∼10 cm to simulate mouse breathing conditions in the
cages. Overall, the chamber could deliver uniform dispersion within
FIG. 4. Mass concentration across the chamber.35 Reproduced with permission
from Peng X et al., ASN Neuro 10, 175909141878230 (2018). Copyright 2018 ASN
Neuro.
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FIG. 5. Size distribution of Alternaria aerosol in three different levels. The Y axis
stands for particle number concentration dN/dlogDp (#/cm3), while the X axis
represents particle size on a logarithmic scale.
the two porous aluminum plates that separated the aerosol inlet and
the exhaust.
B. Nebulized aerosol suspension in different levels
The concentration of aerosol suspension in the chamber (Fig. 5)
could be controlled through changing the aqueous solution concen-
tration, resulting in different levels of mass concentration. Three
different aqueous solution concentrations of Alternaria extract of
0.13 g/l, 0.26 g/l, and 0.52 g/l were nebulized into the chamber
through an atomizer. The size distribution was acquired through the
SMPS. The higher solution concentration leads to the higher total
number concentration in the chamber aerosol suspension without
significantly changing the particle mode diameter of 100 nm.
Four different types of target pollutants were nebulized into the
chamber at a controlled number/mass concentration (Figs. 6 and 7).
While the mode diameters of these aerosol range from 53 nm to
109 nm, all of them can pass from the lungs into the bloodstream and
extra-pulmonary organs. The higher number concentration does not
always result in the higher mass concentration since larger size par-
ticles dominate the total mass concentration. For example, the swine
dust extract had a much lower total mass concentration than that
of the Alternaria extract (Fig. 7) even though it had a significantly
higher number concentration (Fig. 6).
The mass concentration could be controlled from the micro-
gram per cubic meter range to milligram per cubic meter range
(Fig. 7). The chamber was saturated with continuous aerosol injec-
tion and remains consistent throughout the whole experiment, pro-
viding a much more effective and protracted dose delivery than the
intranasal method. We have conducted separate tests with animal
subjects for a full week exposure. For the 3 exposure tests where
the target concentration was 1.5 mg/m3, we measured an average
concentration of 1.47 ± 0.03 mg/m3. For the 8 exposure tests where
the target concentration was 1.3 mg/m3, we measured an average
concentration of 1.2 ± 0.13 mg/m3.
C. Powder-silica aerosol from SSPD 3433
Occupational exposures in different trades range from the low-
est on operation engineers (0.075–0.720 mg/m3) to the highest on
painters (1.28–13.5 mg/m3),36 which significantly exceeds the US
Occupational Exposure Limit (OEL) of 0.05 mg/m3 for respirable
silica.37
To simulate exposures to respirable silica among construc-
tion sites in the USA, two 4-h silica doses were injected into the
chamber each day (Fig. 8). The first dose was given from 8 a.m.
to 12 p.m., while the second dose was given from 4 p.m. to 8 p.m.
Figure 8 shows ten doses injected over 5 days with an average dose
FIG. 6. Size distribution comparison of
four different nebulized target pollutants
from SMPS.
FIG. 7. Consistent mass concentration of
target pollutants over time.
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FIG. 8. Mass concentration of powder sil-
ica aerosol throughout the five-day expo-
sure.
FIG. 9. Size distribution of powder silica aerosol. The vertical axis stands for
particle number distribution dN/N/dlogDp [1/log(µm)], while the horizontal axis
represents particle size on a logarithmic scale.
concentration of around 5 mg/m3 and the overall average concentra-
tion of 1.43 mg/m3. Figure 9 shows the size distribution of dispersed
silica powder with a mode of around 306 nm.
V. CONCLUSION
Here we developed a large-scale multipurpose animal exposure
chamber for health effect investigation of air pollutants. Compared
to other chamber systems featuring nose-only or activity-limited
whole-body exposure, this system provides continuous exposure
through the natural inhalation route at controlled concentration,
size distribution, and duration for chronic, sub-chronic, and acute
epidemiological studies. Our method is also easily reproducible
and has the potential to mimic the real atmospheric environment
by adding multiple air contaminants at the same time for health
investigations.
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